$MFST $ICBU Joint Venture News Today courtesy of Full

New Post Public Reply Private Reply Replies (0) Message Board
MicroCapStocksRock budfoxfun #36007
$MFST $ICBU Joint Venture News Today courtesy of Full Impact Stock Picks here:  http://www.fullimpactstockpicks.com


Image

MEDIFIRST SOLUTIONS, INC. to Update Shareholders

Medifirst Solutions Inc. (QB) (USOTC:MFST)

Today :  Friday 7 March 2014

MEDIFIRST SOLUTIONS, INC. to Update Shareholders

Company Announces a New Product, the Successful Launch of Its Online IT Service Company and Further Plans for the Legal Marijuana  Industry

MANALAPAN, NJ--(Marketwired -  Mar 7, 2014 ) - MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would like to take this opportunity to keep its shareholders updated about ongoing company developments. Commented CEO Bruce J. Schoengood, "I am thrilled to see that Florida has passed a groundbreaking bill in clearing its first hurdle to make medical marijuana legal. The 11-1 vote by the House Subcommittee on Criminal Justice was the first time in modern history that the Florida Legislature voted to approve any marijuana related product. Medifirst will continue to be aggressive in setting up  its infrastructure and getting in on the ground floor in this burgeoning industry." Here are the latest company updates.

LEGAL MEDICAL MARIJUANA--
Medifirst Solutions, Inc. and CEO Bruce Schoengood is pleased to announce that it has begun discussions with IMD Companies, Inc., (OTC Pink: ICBU) and Chairman Richard Wilson to explore joint ventures and business affiliations. Commented CEO Schoengood, "IMD and Mr. Wilson offer superior services and technology and management with a wealth of experience. It would be exciting for both our companies to join forces and work together in this explosive new industry of legal marijuana and I look forward to keeping our shareholders updated on our progress." As previously announced, Medifirst has filed for two publication trademarks "Marijuana News & Report" and "Colorado Buds" and both applications have been completed and processed and can be viewed on the USPTO website. Medifist will be filing a publication trademark for a Florida magazine which will be announced when the filing is completed.

NEW PRODUCT: ZEOLITE SOLUTIONS--
In addition to the just announced Atmospheric Water Solutions which creates pure drinking water from air, Medifirst is pleased to add a new health and wellness product; Zeolite Solutions from Empire Fresh. To be featured at our booth for the IECSC show  March 9th at the Javits Center. Zeolites are used in cosmetics to remove any unwanted, harsh or unnecessary odors, toxins, free radicals and ions from the skin. It also reduces odors, cross contamination, and the spread of bacteria and allergens. Commented CEO Schoengood, "This adds an all natural and environmentally friendly product to our anti-aging skincare  program and services. Reducing pollutants and toxins in the home environment is an important and overlooked factor in maintaining general health as well as healthy skin. We invite you to visit by booth 211 to see all our products."

INCREASED REVENUE--
Medifirst is pleased to announce that with the acquisition of Consumer Resources Consultant's Inc., a Florida based remote IT company and the new addition of the Atmospheric Water Solutions machines, it has seen a dramatic increase of revenue which will be reflective on its Q1 2014 financials. Said CEO Schoengood, "We have been very patient and deliberate in building the company  infrastructure and bringing value to shareholders. I am very pleased to see the company add revenue to its balance sheet and our expectations are for continued growth. I'd like to thank all our shareholders for their continued support."

About Medifirst Solutions, Inc.
Medifirst Solutions, Inc. is a Nevada corporation that is headquartered in New Jersey. The company seeks innovative medical and healthcare products and technologies which are targeted to both medical and healthcare professionals as well as everyday consumers. Medifirst Solutions is developing and establishing both consumer and professional medical and cliental to be used as a pipeline that will allow for distribution of our new products and services. For more details visit  www.medifirstsolutions.com for more  information . Medifirst Solutions will continue to offer its services under its recently announced Health and Wellness Division, Medi-First Light Therapy Systems. Visit  www.medifirstusa.com and www.bocamedicalspa.com for more product information.

Forward-Looking Statements: The statements in this press release that relate to the company's expectations with regard to the future impact on the  company's results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control. Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission. Since the  information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. We make no commitment to disclose any subsequent revisions to forward-looking statements.

Contact:
Medifirst Solutions, Inc.
Investor Relations
Phone:  (732) 786-8044
Email:  info@medifirstsolutions.com
Website:  www.medifirstsolutions.com

My Favorite plays are on the Nasdaq DIP and RIP Board http://investorshangout.com/NASDAQ-DIP-and-RIP-87909/
My Favorite Paid chat room with amazing chart setups is The Trading Stock Lounge http://www.thetradingstocklounge.com/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

FDA Greenlights Kisqali®: A Major Step for Breast Cancer Care

Updated Category News Views 203

Kisqali® Receives FDA Approval for Early Breast Cancer Treatment Novartis has some exciting news for oncology: the US Food and Drug Administration (FDA) has officially approved Kisqali® (ribociclib) as a treatment for patients diagnosed with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer...

Continue Reading
Ålandsbanken Abp Launches SEK 350M Additional Tier 1 Notes Series

Updated Category News Views 162

Ålandsbanken Abp Issues SEK 350,000,000 Additional Tier 1 Notes Ålandsbanken Abp, a prominent player in the banking industry, recently made waves in the financial market by issuing Additional Tier 1 floating rate notes amounting to SEK 350,000,000. The issuance marks a significant step in Ålandsbanken's strategic move to strengthen its capital position and enhance its...

Continue Reading
Harbour BioMed's 2025 Achievements and Future Prospects

Updated Category News Views 249

Harbour BioMed Achieves Significant Milestones in Interim Results Harbour BioMed (HKEX: 02142) is a prominent biopharmaceutical company focused on developing innovative antibody therapeutics, particularly in the fields of immunology and oncology. The company shared its impressive interim results for the first half of the year, showcasing remarkable growth and strategic...

Continue Reading
Innovative Investment Fuels Okika Devices' Future Growth Strategy

Updated Category News Views 187

Strategic Investment Boosts Okika Devices Advancement Colorado ONE Fund, which is part of the ONE Funds initiative, has made a major investment in Okika Devices, a company recognized for its innovation in Field Programmable Analog Array (FPAA) technology. This investment aligns with Colorado ONE Fund's mission to support technologies that advance the local innovation...

Continue Reading
Investors Take Note: Legal Options for Shareholders Explored

Updated Category News Views 61

Exploring Legal Options for Investors in Major Companies In recent developments, Halper Sadeh LLC, a reputable law firm focusing on investor rights, is carefully examining three significant companies for potential violations of federal securities laws. This investigation centers around the actions and decisions made by these firms, which may affect shareholders' rights...

Continue Reading